Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Platypus milk protein could ‘save lives’
Researchers from Australia’s national science agency, CSIRO, have discovered why platypus milk is so potent.

Protein contains unique antibacterial properties 

Australian scientists are one step closer to using platypus milk to save human lives.

In 2010, researchers discovered that platypus milk contained unique antibacterial compounds that could be used to combat superbugs. Now a team of researchers from Australia’s national science agency, CSIRO, have discovered why platypus milk is so potent
.

The research has been published in the journal, Structural Biology Communications.

“Platypus are such weird animals that it would make sense for them to have weird biochemistry,” said lead author Dr Jane Newman. “By taking a closer look at their milk, we’ve characterised a new protein that has unique antibacterial properties with the potential to save lives.”

Platypuses are unique mammals in that they feed their young by secreting milk through the pores of their skin. Exposing the mother’s highly nutritious milk to the environment, however, leaves young open to the threat of bacteria.

Dr Julie Sharp from Deakin University, who worked with CSIRO on the project, said this was why researchers believed the milk contained a protein with antibacterial characteristics.

Employing CSIRO’s Collaborative Crystallisation Centre, the scientists successfully recreated the milk protein, then deciphered its structure to get a better understanding of it.

The scientists dubbed the protein the ‘Shirley Temple’ due to its ringlet-like shape. Interestingly, they discovered the protein has a novel fold in its structure, which they say will inform future drug research.

"Although we’ve identified this highly unusual protein as only existing in monotremes, this discovery increases our knowledge of protein structures in general, and will go on to inform other drug discovery work done at the Centre," said Dr Newman.

The team are now seeking collaborators to take the potentially life-saving platypus research to the next stage.

Image (C) Laura Romin and Larry Dalton.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
Applications open for BEVA Back in the Saddle

The British Equine Veterinary Association (BEVA) has opened applications for its 'Back in the Saddle' coaching programme.

The online scheme offers structured group coaching for members wanting to reflect on their career path and regain clarity. Members may be returning to work after leave, uncertain about next steps or reassessing direction.

Attendees will benefit from impartial guidance and practical tools to support their professional development. Members are encouraged to take a 'proactive, future-focused approach' to their careers.

The sessions, taking place on Wednesdays from 7.30pm-9pm, are open to BEVA members with more than five years' experience. The first session takes place on Wednesday, 3 June 2026.

Applications will close on Wednesday, 27 May 2026.